BioCentury
ARTICLE | Company News

FDA to review BTG's Varisolve

April 12, 2013 11:54 PM UTC

BTG plc (LSE:BTG) said FDA accepted for review an NDA for Varisolve to treat varicose veins. The company submitted the application in early February. The exact PDUFA date is not disclosed, but BTG sai...